Calyxo, founded with a mission to revolutionize kidney stone care, focuses on developing advanced medical devices that enable urologists to achieve superior clinical outcomes safely and effectively. Their flagship product, the CVAC® System, offers multiple capabilities including ureteroscopy, laser lithotripsy, microjet irrigation, dynamic aspiration, and stone collection. Calyxo aims to set a new standard in the market for kidney stone retrieval with their innovative SURE (Steerable Ureteroscopic Renal Evacuation) Procedure.
Notable figures affiliated with Calyxo include experienced urologists and medical device experts who contribute to the company's robust clinical evidence and product development. The company has garnered attention from key investors in the medical technology sector, reflecting confidence in its potential for significant impact. Calyxo's achievements include the successful implementation of the SURE Procedure, which has been recognized for its efficacy and safety, positioning the company as a leader in kidney stone management solutions.
